Close Menu

NEW YORK – The US Food and Drug Administration announced Thursday that South Korean molecular diagnostic firm GeneMatrix received Emergency Use Authorization for its SARS-CoV-2 molecular test. 

The company's NeoPlex COVID-19 Detection Kit uses RT-PCR to detect SARS-CoV-2 nucleic acid from upper and lower respiratory specimens, including nasal swabs, sputum, and tracheal aspirates.

The test can be performed by high-complexity CLIA-certified laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.